Opticaresp. z o.o.

Other retail sale of new goods in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2023-08-11
Share capital
5,000.00 PLN
Registered address
ul. Warzywna 20, 35-310 Rzeszów, Poland

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$2,530

Filing timeliness

Financial statements were filed on time, on average 9 days early.

  • 2025filed
  • 202410/07/2025
  • 202303/07/2024
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Division · Retail trade6,689 / 9,929
Top 67%
City · Rzeszów1,673 / 3,782
Top 44%
Voivodeship · Podkarpackie5,519 / 10,822
Top 51%
Country · Poland152,412 / 298,279
Top 51%

Results vs industry

Revenue
This companyUSD 267.13kMedianUSD 366.09kAverageUSD 2.17m
Net profit
This companyUSD 25.58kMedianUSD 8.59kAverageUSD 88.23k
Operating costs
This companyUSD 239.02kMedianUSD 334.21kAverageUSD 2.03m
Assets
This companyUSD 65.82kMedianUSD 230.31kAverageUSD 1.19m

National Health Fund (NFZ) contracts

Opticare has been an NFZ healthcare provider since 2023. In 2026 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 0.00 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Provision of medical devicespodkarpackie1USD 0.00

Authorized Representatives

Ewelina Beata Kądziołkaage 48 – Management Board Member
Rafał Sławomir Wiluszage 42 – President of the Management Board

Manner of representation

Each member of the management board independently.

Ownership

OwnerSharesShare valueStake
50$675.3150%
50$675.3150%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2023-08-14.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$9,915

FAQ

Last updated: 2026-04-24